Aeras convened a meeting of health economic and TB experts on July 18-19, 2012, to develop a research agenda that would evaluate the economic value of a TB vaccine. Nearly 30 participants at the meeting reviewed the global TB epidemiology and health economic literature to identify the key factors that drive health and economic impact of TB vaccination and to pinpoint where better information or research would fill critical knowledge gaps to better inform decision makers. The result of the meeting was a rich research agenda to guide the economic work needed to answer key questions the value of TB vaccine development investment and inform public health decision-making at the global and country levels.
AERAS. Economics of TB Vaccine Workshop, July 18-19, 2012. Summary Report. (2012) 18 pp.